Paper35394875
TCR-mimic bispecific antibodies to target the HIV-1 reservoir.
Sengupta S and 24 others. Proc Natl Acad Sci U S A, 2022. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. TCR-mimic bispecific antibodies to target the HIV-1 reservoir. Papers, record 35394875. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35394875
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Bispecific | Major topic |
| HIV Infections | Major topic |
| HIV Seropositivity | Major topic |
| HIV-1 | Major topic |
| CD4-Positive T-Lymphocytes | |
| Humans | |
| Molecular Mimicry | |
| Receptors, Antigen, T-Cell | |
| Virus Latency |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI120634 | NIAID NIH HHS | United States | R01AI120634 | PubMed and NIH | NIH RePORTER |
| T32 GM136577 | NIGMS NIH HHS | United States | T32GM136577 | PubMed and NIH | NIH RePORTER |
| T32 GM007445 | NIGMS NIH HHS | United States | T32GM007445 | PubMed and NIH | NIH RePORTER |
| Howard Hughes Medical Institute | United States | PubMed | PubMed | ||
| F30 AI136704 | NIAID NIH HHS | United States | F30AI136704 | PubMed and NIH | NIH RePORTER |
References97
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9104816 | The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. | J Exp Med | 1997 | https://conductscience.org/library/papers/9104816 | PubMed |
| 2 | 2420472 | The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. | Cell | 1986 | https://conductscience.org/library/papers/2420472 | PubMed |
| 3 | 27428432 | The Effect of Latency Reversal Agents on Primary CD8+ T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication. | EBioMedicine | 2016 | https://conductscience.org/library/papers/27428432 | PubMed |
| 4 | 24658076 | New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. | Nat Med | 2014 | https://conductscience.org/library/papers/24658076 | PubMed |
| 5 | 12684537 | Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12684537 | PubMed |
| 6 | 34242582 | HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens. | Cell Host Microbe | 2021 | https://conductscience.org/library/papers/34242582 | PubMed |
| 7 | 25122219 | Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes. | PLoS Pathog | 2014 | https://conductscience.org/library/papers/25122219 | PubMed |
| 8 | 24725404 | Accumulation of dynamic catch bonds between TCR and agonist peptide-MHC triggers T cell signaling. | Cell | 2014 | https://conductscience.org/library/papers/24725404 | PubMed |
| 9 | 19062316 | Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. | Immunity | 2008 | https://conductscience.org/library/papers/19062316 | PubMed |
| 10 | 21762802 | HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. | J Mol Biol | 2011 | https://conductscience.org/library/papers/21762802 | PubMed |
| 11 | 9360926 | Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. | Science | 1997 | https://conductscience.org/library/papers/9360926 | PubMed |
| 12 | 25402363 | Eradicating HIV-1 infection: seeking to clear a persistent pathogen. | Nat Rev Microbiol | 2014 | https://conductscience.org/library/papers/25402363 | PubMed |
| 13 | 20435924 | Cutting Edge: mechanical forces acting on T cells immobilized via the TCR complex can trigger TCR signaling. | J Immunol | 2010 | https://conductscience.org/library/papers/20435924 | PubMed |
| 14 | 28249141 | Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28249141 | PubMed |
| 15 | 27725635 | Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection. | Nat Rev Drug Discov | 2016 | https://conductscience.org/library/papers/27725635 | PubMed |
| 16 | 20638642 | Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. | Cell Host Microbe | 2010 | https://conductscience.org/library/papers/20638642 | PubMed |
| 17 | 22406268 | Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. | Immunity | 2012 | https://conductscience.org/library/papers/22406268 | PubMed |
| 18 | 9151834 | Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI. | J Virol | 1997 | https://conductscience.org/library/papers/9151834 | PubMed |
| 19 | 19219024 | Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. | Nat Med | 2009 | https://conductscience.org/library/papers/19219024 | PubMed |
| 20 | 29972754 | Chimeric Antigen Receptor Therapy. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29972754 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42753739 | Cancers modulate processing and presentation of p53 neoantigens to evade T cell detection. | Immunity | 2026 | https://conductscience.org/library/papers/42753739 | PubMed |
| 42619491 | AlphaFold 3 prediction of TCR mimic Fv - pMHC complex structures and their validation and optimization. | MAbs | 2026 | https://conductscience.org/library/papers/42619491 | PubMed |
| 41279654 | A TCR-mimic bispecific antibody reduces HIV-1 provirus and delays viral rebound in HLA-matched humanized mice. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279654 | PubMed |
| 39672954 | Targeting peptide antigens using a multiallelic MHC I-binding system. | Nat Biotechnol | 2025 | https://conductscience.org/library/papers/39672954 | PubMed |
| 39594730 | Unlocking Intracellular Oncology Targets: The Unique Role of Antibody-Based T-Cell Receptor Mimic (TCRm) Therapeutics in T-Cell Engagers (TCEs) and Antibody-Drug Conjugates (ADCs). | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39594730 | PubMed |
| 39203549 | Adeno-Associated Virus (AAV)-Delivered Exosomal TAT and BiTE Molecule CD4-αCD3 Facilitate the Elimination of CD4 T Cells Harboring Latent HIV-1. | Microorganisms | 2024 | https://conductscience.org/library/papers/39203549 | PubMed |
| 39141734 | Parsing digital or analog TCR performance through piconewton forces. | Sci Adv | 2024 | https://conductscience.org/library/papers/39141734 | PubMed |
| 39109538 | TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models. | Emerg Microbes Infect | 2024 | https://conductscience.org/library/papers/39109538 | PubMed |
| 38278966 | Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells. | Nat Immunol | 2024 | https://conductscience.org/library/papers/38278966 | PubMed |
| 38236978 | Impact of HLA class I functional divergence on HIV control. | Science | 2024 | https://conductscience.org/library/papers/38236978 | PubMed |
| 38022650 | Conformation-selective rather than avidity-based binding to tumor associated antigen derived peptide-MHC enables targeting of WT1-pMHC low expressing cancer cells by anti-WT1-pMHC/CD3 T cell engagers. | Front Immunol | 2023 | https://conductscience.org/library/papers/38022650 | PubMed |
| 37966222 | Experimental models for HIV latency and molecular tools for reservoir quantification-an update. | Clin Microbiol Rev | 2023 | https://conductscience.org/library/papers/37966222 | PubMed |
| 37649123 | The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37649123 | PubMed |
| 37455333 | Challenges and solutions for therapeutic TCR-based agents. | Immunol Rev | 2023 | https://conductscience.org/library/papers/37455333 | PubMed |
| 37339184 | Harnessing αβ T cell receptor mechanobiology to achieve the promise of immuno-oncology. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37339184 | PubMed |
| 35967436 | TCR-like antibodies targeting autoantigen-mhc complexes: a mini-review. | Front Immunol | 2022 | https://conductscience.org/library/papers/35967436 | PubMed |
Genes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35394875
GET https://conductscience.org/api/papers/v1/35394875/authors?page=2